drugset / Trial / NCT00033176

Immune Restoration by Lipoic Acid in AIDS

NCT00033176

RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the immunomodulatory and antiviral effects of the glutathione-restoring dithiol, alpha lipoic acid (ALA) in HIV-infected persons unresponsive to highly active antiretroviral treatment (HAART).

Timeline

Start
2002-02
Primary completion
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject alpha-lipoic acid Small molecule 300 mg

Indications